Epizyme Inc.

NASDAQ: EPZM · Real-Time Price · USD
1.47
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Epizyme Revenue Breakdown

Period Ending Dec 31, 2021 Dec 31, 2020
Product Revenue 30.92M 11.47M
Product Revenue Growth +169.61% n/a
Collaboration Revenue Revenue 6.5M 4.29M
Collaboration Revenue Revenue Growth +51.53% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 24.11M 27.2M 30.86M 32.79M 33.89M 36.41M 35.02M 30.57M 32.66M 26.93M 23.53M 17.09M 15.7M 11.99M 12.17M 11.53M 10.91M 9.36M 8.43M 9.31M 11.17M 8.27M 7.58M 7.52M 7.42M 5.85M 6.02M 6.68M 5.97M 5.24M
Selling, General, and Administrative Revenue Growth -11.37% -11.85% -5.89% -3.24% -6.92% +3.98% +14.53% -6.38% +21.29% +14.44% +37.69% +8.86% +30.97% -1.52% +5.58% +5.63% +16.60% +11.02% -9.45% -16.64% +35.08% +9.09% +0.77% +1.32% +26.99% -2.84% -9.87% +11.83% +14.00% n/a
Research and Development Revenue 28.05M 29.78M 28.86M 34.55M 34.86M 32.7M 33.68M 25.74M 26.35M 25.16M 38.26M 26.58M 40.91M 26.9M 21.84M 27.03M 31.35M 25.62M 28.93M 28.74M 27.29M 24.7M 28.38M 23.89M 21.45M 17.74M 16.82M 16.79M 20.55M 57.05M
Research and Development Revenue Growth -5.80% +3.21% -16.48% -0.89% +6.59% -2.90% +30.86% -2.33% +4.73% -34.23% +43.94% -35.03% +52.09% +23.16% -19.20% -13.78% +22.34% -11.44% +0.67% +5.31% +10.52% -12.99% +18.82% +11.37% +20.91% +5.48% +0.18% -18.31% -63.98% n/a